Monopoly wharf.
Here are some very rough numbers. Working on a 66% probability of success and a value of $7.3bn per indication. That $14.5bn for the first three that have passed PH2. Assuming Angelmans is success ful. Thats coming of Reatas Valuation that Jon flagged.
I really can’t find and numbers for successful animal trials. But being a platform pipeline, with stellar animal results so far , let’s bump it up from 10% yo 20%. Because the animal models are so good and the mechanisms of action is so well understood that might even be a little low. Assuming 5 indications which is half of Jon’s less than 10 comments. Which I believe will be on the low side. After 4 positive hits last round and considering our fat bank account why wouldn’t he double down this time to 8.
But 5 X $7.3bn X 10% =$3.65bn. Or 20% =$7.3bn.
Let’s not forget to add in $4bn for NNZ2486 licensed to ACAD. If that equals 5 x royalties at peak sales. Not an exact science but it’s a start.
That totals $26.8Bn USD. Or $40.2Bn AUD.
That gives $326 per share. I wonder the CEO and BOD have very happy relaxed grins. Even if my calculations are halved we still get $163 per share.
I realise that sounds crazy and am more than happy to hear different valuations. It’s just that there has never been a drug like this before. Not that I’ve heard of,
Here is some reading that will help understand just how valuable NEU’ pipeline has become.
https://www.tandfonline.com/doi/full/10.1517/21678707.2013.752128
- Forums
- ASX - By Stock
- Pipeline-in-a-drug
Monopoly wharf. Here are some very rough numbers. Working on a...
-
-
- There are more pages in this discussion • 176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.46 |
Change
-0.040(0.21%) |
Mkt cap ! $2.487B |
Open | High | Low | Value | Volume |
$19.50 | $19.59 | $19.35 | $1.200M | 61.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20 | $19.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.47 | 1294 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31 | 19.470 |
3 | 166 | 19.460 |
5 | 314 | 19.450 |
11 | 621 | 19.440 |
5 | 436 | 19.430 |
Price($) | Vol. | No. |
---|---|---|
19.480 | 595 | 2 |
19.490 | 302 | 4 |
19.500 | 766 | 5 |
19.510 | 1098 | 7 |
19.520 | 392 | 7 |
Last trade - 12.15pm 10/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online